Bristol-Myers Positive, Cooper Jumps, WBD Declines

Stock Movers


Bristol-Myers (BMY)

  • Analysts are citing a positive readacross to Bristol-Myers from positive results for Bayer's experimental stroke-prevention drug
  • Cantor: Bayer’s data supports confidence in BMY’s own program in secondary stroke prevention
  • Earlier this month:  shares fell after one of its most important experimental medicines appeared unlikely to benefit patients who had suffered a heart complication, another setback for the drugmaker’s product pipeline


Cooper (COO)

  • Maker of medical devices and surgical instruments;
  • Activist investors Browning West wrote a letter to the board saying its “inadequate” oversight has led the company to significantly underperform and miss financial guidance
  • Calls for urgent change at the Board to refocus the co. and appoint Browning West’s director candidates
  • Urges Cooper to pause any potential restructuring efforts until Browning West’s recommended directors are seated so that any restructuring is optimized in scope and magnitude
  • Reuters reported earlier this month that Browning West owns about 4% of Cooper


WBD

  • Netflix, Comcast and Paramount Skydance all submitted bids for Warner Bros. Discovery by the Nov. 20 deadline for a first bid
  • Comcast and Netflix are most interested in the film and TV library; Paramount is willing to buy the whole company
  • Fourth owner in seven years
  • Warner Bros. may not reach a deal with any of the suitors and may continue its current plan to separate its flagging cable networks from the rest of the businesses next year

See omnystudio.com/listener for privacy information.

2025-11-24 3 min Transcript

Available Results

Generated results are saved to your library for reuse and search.

No generated results are available for this episode yet.

Transcript

Open the Transcript tab to load the transcript.

Chapters

No chapters available.